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Objectives: To determine whether a prophylactic second dose of antibiotics is justified when severe blood loss and~or 
prolonged operation time occurs during aortoiliac reconstructions. 
Methods: We measured the cefuroxime concentration in venous blood serum and subcutaneous fat tissue of 30 patients 
who underwent elective aortoiliac reconstruction after a single intravenous dose of 1500 mg cefuroxime. 
Results, The mean blood loss was 1912 ml (range 200-7000). The mean operation time was 212 min (range 70-330). The 
cefuroxime concentration in blood serum 30 min after the gift varied from 53.7-561.6 mg/1 and during closure of the 
abdominal incision from 13.2-90.0 mg/I. Taking the minimum inhibitory concentration for Staphylococcus species as 1.0 
mg/l, we found an adequate prophylactic serum cefuroxime concentration in all patients. There was a statistically 
significant correlation between serum cefuroxime concentration and blood loss (p=O.01) and operation time 
(p = 0.0001). 
Conclusions: Although serum concentration of cefuroxime is greatly influenced by blood loss and operation time, a second 
dose of cefuroxime in aortoiliac reconstructions i  not necessary if the operation is completed within 5.5 h and if 
perioperative blood loss does not exceed 7000 ml. 
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Introduction 
Most surgeons are convinced of the importance of the 
prophylactic use of antibiotics during major surgical 
procedures. However, there is no consensus about 
dose and time of administration. There is growing 
evidence that a single preoperative dose for prophy- 
laxis is as good as multiple doses; a previous study 
from our clinic shows that a single intravenous dose of 
20 mg/kg cefuroxime gave adequate prophylaxis for 6 
1 h in coronary artery grafting. In spite of this evidence, 
many surgeons cannot resist the temptation to give a 
second dose of antibiotic where there is severe blood 
loss during surgery or prolonged operation time. 
There are no known prospective studies that justify a 
second ose for these reasons. We therefore performed 
a prospective single centre study in which we meas- 
ured the cefuroxime concentration i venous blood 
serum and subcutaneous fat tissue in patients under- 
going an aortoiliac reconstruction, and correlated this 
with perioperative blood loss and operation time. 
*Please address all correspondence to: M.S.W. van Dijk-van Dam. 
Patients and Methods 
Patients undergoing aortoiliac reconstruction were 
asked to participate in our study. When there was a 
sensitivity to penicillins and cephalosporins, or when 
the patient had been exposed to any antibiotics within 
72 h before operation, the patient was excluded from 
the study. Thirty consecutive patients were included 
after giving informed consent. During anaesthetic 
induction the patients received 1500 mg cefuroxime 
intravenously and endotracheal intubation followed. 
Two venous erum samples of 10 ml each were taken 
from a central venous catheter 30 min later. Two 
samples were taken to minimise laboratory variables. 
During closure of the abdominal incision another two 
venous samples were taken, along with a subcuta- 
neous fat tissue biopsy of 2 × 2 cm from the abdominal 
wall. We noted perioperative blood loss and operation 
time. The four venous blood samples were centrifuged 
and frozen together with the fat tissue biopsies. 
Determination of the cefuroxime concentration was 
performed when all the samples of the 30 patients had 
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been collected. Determination of the serum cefurox- 
ime concentration was performed with high pressure 
liquid chromatography as described by Koot et al. 1 For 
determination of the cefuroxime concentration in 
subcutaneous fat we used the following method: i g of 
subcutaneous fat was homogenised in hexane and 
phosphate-buffered isotonic salt solution containing 
the internal standard cefalexin. After centrifugation 
the supernatant was analysed for cefuroxime content 
using high pressure liquid chromatography. Cefurox- 
ime levels were corrected for blood contamination of
the fat tissue samples by comparing the haemoglobin 
concentrations in fat and blood. The cefuroxime 
concentration of the two serum samples that were 
taken at the same time were averaged. The results 
were analysed by multivariant regression. 
Results 
Thirty patients were included; 27 men and three 
women. The mean age and Quetelet-index was, 
respectively, 69 years (range 51-83) and 25 kg /m 2 
(range 18-32). The mean creatinine concentration was 
112 mM/1 (range 68-335). In five patients the creatinine 
concentration was elevated; 153-335 mM/1. All the 
operations were primary and elective. Twenty-three 
patients received an aortic bifurcation prothesis and 
seven patients an aortic tube prothesis (Table 1). The 
mean blood loss was 1912 ml (range 200-7000), 2154 
ml for an aortic bifurcation prothesis (range 500-7000) 
and 1114 ml for an aortic tube prothesis (range 
200--4000). The mean operation time was 212 min 
(range 70-330), 227 min for an aortic bifurcation 
prothesis (range 135-330) and 143 min for an aortic 
tube prothesis (range 70-210). The serum cefuroxime 
concentration 30 min after the dose varied from 
53.7-561.6 mg/1, and during closure of the abdominal 
incision from 13.2-90.0 mg/1 (Table 2). The cefuroxime 
concentration i  subcutaneous fat varied from 5.2-26.2 
/zg/g. Taking the minimum inhibitory concentration 
for Staphylococcus species as 1.0 rag~l, we found an 
adequate prophylactic cefuroxime concentration i  all 
Table 1. Results; blood loss and operation time. 
Aortic 
All Patients bifurcation Aortic tube 
(n=30) (n=23) (n=7) 
Mean blood loss 1912 2154 1114 
(ml) (200-7000) (500-7000) (200-4000) 
Mean operation time 212 227 143 
(rain) (70-330) (135-330) (70-210) 
Table 2. Cefuroxime concentrations in blood serum and 
subcutaneous fat. 
Cefuroxime 
concentration 
Serum, 30 min after i.v. injection (mg/1)* 53.7-561.6 
Serum, during dosing incision (mg/1)* 13.2-90.0 
Subcutaneous fat (~g/g) 5.2-26.2 
*The minimum inhibitory concentration f r Staphylococcus species i
1.0 rag/1. 
patients during the operation after a single intra- 
venous dose. There was a statistically significant 
correlation between cefuroxime concentration and 
blood loss (p = 0.01) (Table 3). This was also found for 
operation time (p = 0.0001). Combining the variables 
blood loss and operation time and the variables blood 
loss, operation time and weight of the patient, also 
gave statistically significant correlations with p-values 
of, respectively, 0.0004 and 0.001. No statistically 
significant correlation was found between serum 
concentration and the weight of the patient (p = 0.93), 
even when the variables blood loss and weight of the 
patient were combined (p = 0.02). 
Discussion 
In our clinic, we use cefuroxime for prophylaxis in 
arterial reconstructions. It is a semi-synthetic ceph- 
alosporin antibiotic, effective against many Gram- 
positive and Gram-negative bacteria. The elimination 
half-life is approximately 1.5 h and at least 95% of the 
drug appears in the urine unchanged. Serum protein 
binding has been found to be 33% .2 There is already an 
optimal serum concentration half an hour after intra- 
venous injection. The dose of cefuroxime is the same 
for patients with impaired kidney function because 
the dose is determined by the volume of distribution. 
The long elimination half-life of cefuroxime means 
that even 6 h after the dose there remains an adequate 
concentration of prophylaxis. This has already been 
Table 3. p-values. 
Cefuroxime 
concentration n serum 
Blood loss p=0.01* 
Operation time p=0.0001* 
Weight of patient p=0.93 
Blood loss and operation time p=0.0004* 
Blood loss and weight p=0.02 
Blood loss, operation time and weight p=0.001* 
*Statistically significant. 
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shown by Koot et aI. in 19921 and is confirmed in our 
study. A striking finding was the range of cefuroxime 
concentrations in serum as well as tissue samples. 
Serum concentrations did not always correlate with fat 
tissue concentrations. This phenomenon is also men- 
tioned in literature, 3'4 but no explanation is given. The 
cefuroxime concentrations in serum and subcutaneous 
fat tissue found in our study correspond with the 
concentrations reported in the literature. 2"3'5 By assay- 
ing the cefuroxime concentration i subcutaneous fat 
tissue we proved that there is an adequate level to 
prevent superficial wound infection in all patients. We 
assume that there is also an adequate cefuroxime 
concentration i the tissue surrounding the graft. 
Our conclusion, based on the results from this study, 
is that although the serum concentration of cefurox- 
ime is greatly influenced by blood loss and operation 
time, a second dose of cefuroxime during aortoiliac 
reconstructions i unnecessary if the operation is 
completed within 5.5 h and peroperative blood loss is 
not more than 7000 ml. 
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